FORM OF STANDSTILL AND LOCK-UP AGREEMENTStandstill and Lock-Up Agreement • January 17th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
This Standstill and Lock-Up Agreement (this “Agreement”) is made and entered into as of [●], 2018 (the “Effective Date”), by and among DanDrit Biotech USA, Inc., a Delaware corporation (“Parent”), Weird Science, LLC, a California limited liability company (the “Majority Stockholder”) and RS Group ApS, a Danish limited company and a stockholder of Parent (“RS Group” and together with Majority Stockholder, the “Stockholders” and each, a “Stockholder”). Parent, Majority Stockholder and RS Group are each referred to as a “Party” or collectively as the “Parties.”
FORM OF INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 17th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
This Investor Rights Agreement (this “Agreement”) is made and entered into as of [●], 2018 (the “Effective Date”), by and among DanDrit Biotech USA, Inc., a Delaware corporation (“Parent”), Weird Science, LLC, a California limited liability company (“Majority Stockholder”) and RS Group ApS, a Danish limited company and a stockholder of Parent (“RS Group” and together with Majority Stockholder, the “Stockholders”). Parent and each Stockholder are each referred to as a “Party” or collectively as the “Parties.”
DANDRIT BIOTECH USA, INC., DANDRIT ACQUISITION SUB, INC., ENOCHIAN BIOPHARMA INC. AND WEIRD SCIENCE LLC AGREEMENT AND PLAN OF MERGER Dated as of January 12, 2018Agreement and Plan of Merger • January 17th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated January 12, 2018 (the “Effective Date”), is by and among DanDrit Biotech USA, Inc., a Delaware corporation (“Parent”), DanDrit Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), Enochian Biopharma Inc., a Delaware corporation (“Company”), and Weird Science LLC, a California limited liability company and the super majority stockholder of Company (the “Majority Stockholder”). All terms defined in this Agreement are referenced in Section 1.1. Parent, Merger Sub, Company and the Majority Stockholder are each referred to as a “Party” or collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • January 17th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • New York
This License Agreement, effective as of [●], 2018 (the “Effective Date”), is made by and between WEIRD SCIENCE LLC, a California limited liability company (“Licensor”), and ENOCHIAN BIOPHARMA INC., a Delaware corporation (“Licensee”).
